Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $52.19.

A number of research analysts have weighed in on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Bank of America dropped their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Finally, Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in the company. Lindbrook Capital LLC raised its holdings in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. raised its position in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the period. Signaturefd LLC boosted its stake in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after buying an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp grew its stake in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares during the period.

Acadia Healthcare Stock Down 3.6 %

Shares of NASDAQ ACHC opened at $27.37 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s fifty day simple moving average is $35.62 and its 200 day simple moving average is $43.35. The firm has a market cap of $2.54 billion, a PE ratio of 8.97, a P/E/G ratio of 1.46 and a beta of 1.38. Acadia Healthcare has a 12-month low of $26.72 and a 12-month high of $82.41.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.